Emerging strategies for optimizing clinical chemistry performance. Performance partnerships are playing an increasingly important role.
作者信息
Hill Jeffrey
出版信息
MLO Med Lab Obs. 2017 Jun;49(6):24, 26.
PMID:29952456
Abstract
摘要
相似文献
1
2
Reportable interval of patient examination results and ISO 15189.患者检查结果的可报告区间与ISO 15189
Clin Chem Lab Med. 2005;43(11):1278. doi: 10.1515/CCLM.2005.220.
3
[Continuing education is the correct way to influence the use of laboratory analyses].
Lakartidningen. 2004 Feb 5;101(6):495-6.
4
[Inappropriate use of diagnostic laboratory tests--a perspective from decision making analysis].[诊断实验室检查的不当使用——基于决策分析的视角]
Tidsskr Nor Laegeforen. 2000 Aug 20;120(19):2294-8.
5
A laboratorian's perspective on evaluation and implementation of new laboratory tests.实验室工作人员对新实验室检测项目评估与实施的看法。
Clin Chem. 1997 Sep;43(9):1771-80.
6
Who defines the medical requirements of analytical tests?谁来界定分析检测的医学要求？
J Clin Chem Clin Biochem. 1990 Mar;28(3):125-8.
7
Where does the evidence come from?证据从何而来？
Clin Chem Lab Med. 2006;44(1):1-2. doi: 10.1515/CCLM.2006.001.
8
Day to day precision in clinical chemistry laboratories.临床化学实验室的日常精密度。
Pa Med. 1978 Mar;81(3):33-7.
9
Reliability of 6-h troponin T remains unproven.6小时肌钙蛋白T的可靠性尚未得到证实。
Ann Clin Biochem. 2007 Jan;44(Pt 1):94; author reply 94-5. doi: 10.1258/000456307779595977.
10
[Can laboratories rely on diagnostics-companies?].
Lakartidningen. 2000 May 31;97(22):2783.
Zotero 插件